Leibowitz says pay-for-delay deals remain a priority
Friday, 18 November 2011
Ron Knox
US Federal Trade Commission (FTC) Chairman Jon Leibowitz says fighting against “pay-for-delay” settlements in pharmaceutical patent litigation will continue to be a priority for the commission should he be given a second term as chairman.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top